Target General Information
Target ID T00238
Target Name mRNA of NF-kappa B
Synonyms DNAbinding factor KBF2 (mRNA); H2TF1 (mRNA); Lymphocyte translocation chromosome 10 protein (mRNA); Lyt10 (mRNA); NFKB2 (mRNA); Nuclear factor NFkappaB p100 subunit (mRNA); Nuclear factor NFkappaB p52 subunit (mRNA); Nuclear factor of kappa light polypeptide gene enhancer in Bcells 2 (mRNA); Oncogene Lyt10 (mRNA); NFKB2
Target Type Clinical Trial
Gene Name NFKB2
Biochemical Class Target of antisense drug
UniProt ID NFKB2_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease Ulcerative colitis
Example drug DIMS-0150 Phase 3 [523735], [1572592]
Tissue Colon mucosal tissue
Level of differential expression between the patients in the disease section of the tissue and the patients in the normal section of the tissue adjacent to the disease section Fold-change: -0.01
Z-score: -0.03
P-value: 2.56E-01
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of the persons with other diseases not directly affecting the tissue
Target gene expression profiles in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Reference
Ref 523735ClinicalTrials.gov (NCT01493960) The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients. U.S. National Institutes of Health.
Ref 1572592NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.